The bill exempts from schedule I a prescription drug product containing the schedule I controlled substance (product) if the product is:
Approved for prescription use by the United States food and drug administration; and
Designated or rescheduled by the United States drug enforcement agency (DEA).
The exemption applies upon the DEA's designation or rescheduling.
The bill requires that the product be controlled in Colorado in the same manner as the product is controlled by the DEA.
(Note: This summary applies to this bill as introduced.)